Lanreotide Acetate

CAS 127984-74-1 10 current recordsProtein

Who holds supplier records for Lanreotide Acetate? 10 organisations hold a current record for Lanreotide Acetate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: China (4) and India (3); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Lanreotide Acetate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/lanreotide-acetate

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lanreotide Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4India3Country not recorded for 3
Need Lanreotide Acetate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lanreotide Acetate is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201184).

Chemical identity

IUPAC name
acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide
Canonical SMILES
C[C@H]([C@@H](C(=O)N)NC(=O)[C@@H]1CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)C(C)C)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)N)O.CC(=O)O
InChIKey
DEXPIBGCLCPUHE-UISHROKMSA-N
Synonyms
BIM-23014C, Lanreotide acetate, Somatuline, Somatuline depot, Somatuline lp, Somatuline Autogel, RefChem:552347, Lanreotide (acetate), orb1299003, HY-P1959A, ITM-014, BN-52030

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Somatostatin Analog
Mechanism of action
Somatostatin Receptor Agonists

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lanreotide Acetate?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Lanreotide Acetate: ALP PHARM BEIJING CO LTD, BACHEM AMERICAS INC, CHENGDU SHENGNUO BIOPHARM CO LTD (China), Dr. Reddy's Laboratories Ltd. (India), Reliance Life Sciences Pvt. Ltd. (India), SICHUAN DUORUI BIOPHARMACEUTICAL CO LTD, SICHUAN FRONTIER BIOPHARMACEUTICAL CO LTD (China) and Sichuan Huiyu Pharmaceutical Co., Ltd. (China), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lanreotide Acetate Drug Master Files are active?

ALP PHARM BEIJING CO LTD (DMF 24378), BACHEM AMERICAS INC (DMF 33336), CHENGDU SHENGNUO BIOPHARM CO LTD (DMF 39673), Dr. Reddy's Laboratories Ltd. (DMF 39768), Reliance Life Sciences Pvt. Ltd. (DMF 42130), SICHUAN DUORUI BIOPHARMACEUTICAL CO LTD (DMF 41446), SICHUAN FRONTIER BIOPHARMACEUTICAL CO LTD (DMF 39483) and Sichuan Huiyu Pharmaceutical Co., Ltd. (DMF 42318) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Lanreotide Acetate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lanreotide Acetate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.